Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

IMMP stock hub

Immutep Limited has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

IMMPis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
64M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
IMMP
In the news

Latest news · IMMP

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-61.8
P25 -105.6P50 -46.5P75 -3.1
ROIC-38.6
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All IMMP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
197
Groups with data
11
Currency
AUD
Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

23
MetricValue
Cik
0001692528
Company name
Immutep Limited
Country
Australia
Country code
US
Cusip
45257L108
Employees
31
Employees Change
1%
Employees Change Percent
3.33
Enterprise value
$-6.9M
Exchange
NASDAQ
Financial currency
AUD
First seen
2026-05-09
Industry
Biotechnology
Isin
US45257L1089
Last refreshed
2026-05-10
Market cap
$64M
Market cap category
Micro-Cap
Price
$0.45
Price currency
USD
Rev Per Employee
170,472.23x
Sector
Healthcare
Symbol
IMMP
Website
https://www.immutep.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

5
MetricValue
Earnings Yield
-87.42%
FCF yield
-70.53%
P/B ratio
0.97x
P/S ratio
12.12x
PS Forward
3.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

11
MetricValue
Gross Profit
$-49.9M
Net Income
$-56M
Net Income Growth Years
0%
Pretax Margin
-1,059.19%
Profit Per Employee
$-1.8M
ROA
-32.1
Roa5y
-20.43
ROCE
-84.46
ROE
-61.85
Roe5y
-38.46
ROIC
-38.57

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

10
MetricValue
Cagr10y
-17.91%
Cagr1y
-76.91%
Cagr3y
-35.21%
Cagr5y
-33.85%
EPS Growth Years
0
Revenue Growth
62.39x
Revenue Growth Q
91.46x
Revenue Growth Years
2x
Revenue Growth3 Y
22.43x
Revenue Growth5 Y
4.51x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
$0.05
Assets
$98.2M
Cash
$66.1M
Current Assets
$101.4M
Current Liabilities
$34.1M
Debt
$806,834
Debt Equity
$0.01
Equity
$66M
Interest Coverage
-2,164.4
Liabilities
$32.2M
Long Term Assets
$-3.2M
Long Term Liabilities
$-1.9M
Net Cash
$65.3M
Net Cash By Market Cap
$102
Net Cash Growth
-4.11%
Net Debt Equity
$-0.99
Tangible Book Value
$62M
Tangible Book Value Per Share
$0.04
WACC
17.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
2.97
Net Working Capital
$-4.1M
Quick ratio
2.91
Working Capital
$61.9M
Working Capital Turnover
$0.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

2
MetricValue
Buyback Yield
-9.74%
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-86.1%
1Y total return
-76.89%
200-day SMA
1.83
3Y total return
-72.8%
50-day SMA
0.9
50-day SMA vs 200-day SMA
50under200
5Y total return
-87.33%
All Time High
46.67
All Time High Change
-99.04%
All Time High Date
2012-04-17
All Time Low
0.29
All Time Low Change
52.32%
All Time Low Date
2026-04-13
ATR
0.07
Beta
2.36
Ch YTD
-84.41
High
0.45
High52
3.53
High52 Date
2025-12-08
High52ch
-87.37%
Low
0.42
Low52
0.29
Low52 Date
2026-04-13
Low52ch
52.32%
Ma50ch
-50.49%
Premarket Change Percent
-1.13
Premarket Price
$0.43
Premarket Volume
65,967
Price vs 200-day SMA
-75.6%
RSI
33.87
RSI Monthly
34.92
RSI Weekly
30.85
Sharpe ratio
-0.01x
Sortino ratio
0.03
Total Return
-9.74%
Tr YTD
-84.41
Tr1m
25.46%
Tr1w
2.25%
Tr3m
-82.98%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

12
MetricValue
Analyst Count
3
Analyst Count Top
1
Analyst Price Target Top
$1
Analyst Ratings
Hold
Analyst Ratings Top
Hold
Earnings Revenue Estimate
2,530,000x
Earnings Revenue Estimate Growth
-61.79x
Operating Income
$-56.4M
Operating margin
-1,068.1
Price target
$5.5
Price Target Change
$1,133
Price Target Change Top
$124

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

10
MetricValue
Float
1,227,152,220%
Float Percent
83.27%
Net Borrowing
-192,150.1
Shares Insiders
2.66%
Shares Institutions
52.07%
Shares Out
1,473,721,306
Shares Qo Q
0.84%
Shares Yo Y
9.74%
Short Ratio
0.04
Short Shares
0.87

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

61
MetricValue
Adjusted FCF
$-45.9M
Average Volume
40,484,619.05x
Bv Per Share
0.04
CAPEX
$-84,662
Ch10y
-86.1
Ch1m
25.46
Ch1w
2.25
Ch1y
-76.89
Ch3m
-82.98
Ch3y
-72.8
Ch5y
-87.33
Ch6m
-73.61
Change
3.15%
Change From Open
4.55
Close
0.43
Days Gap
-1.34
Depreciation Amortization
1,616,957.2
Dollar Volume
213,833.8
Earnings Date
2026-06-29
Earnings Time
bmo
EBIT
$-56.4M
EBITDA
$-55M
EPS
$-0.04
F Score
2
FCF
$-45.2M
FCF EV Yield
656.71x
FCF Per Share
$-0.03
Financing CF
-140,412
Fiscal Year End
June
Founded
1,987
Goodwill
79,733.5
Investing CF
39,753,364
Is Primary Listing
0
Is Spac
No
Last Earnings Date
2026-02-25
Last Report Date
2025-12-31
Last Split Date
2016-12-28
Last Split Type
Reverse
Ma150
1.87
Ma150ch
-76.15%
Ma20
0.5
Ma20ch
-9.94%
Net CF
-759,461
Next Earnings Date
2026-06-29
Open
0.43
Optionable
Yes
Position In Range
87.46
Post Close
0.45
Postmarket Change Percent
0.87
Postmarket Price
$0.45
Ppne
955,786.3
Pre Close
0.43
Price Date
2026-05-08
Ptbv Ratio
1.03
Relative Volume
0.01x
Revenue
5,284,639x
SBC By Revenue
14.69x
Share Based Comp
776,109
Tr6m
-73.61%
Volume
479,448
Z Score
-0.55
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does IMMP pay a dividend?

Capital-return profile for this ticker.

Performance

IMMP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-76.9%
S&P 500 1Y: n/a
3Y total return
-72.8%
S&P 500 3Y: n/a
5Y total return
-87.3%
S&P 500 5Y: n/a
10Y total return
-86.1%
S&P 500 10Y: n/a
Ownership

Who owns IMMP?

Insider, institutional, and short-interest positioning.

Institutional ownership
+52.1%
Float: +83.3% of shares outstanding
Insider ownership
+2.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
0.0 days to cover
Y/Y dilution
+9.7%
Negative means the company is buying back shares.
Technical

IMMP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
33.9
Neutral momentum band
Price vs 200-day MA
-75.6%
50/200-day relationship not available
Beta (5Y)
2.36
More volatile than the market
Sharpe ratio
-0.01
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About IMMP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current IMMP stock rating?

Immutep Limited is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IMMP analysis?

The full report lives at /stocks/IMMP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for IMMP?

The latest report frames IMMP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the IMMP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.